RNA-targeting CRISPR systems from metagenomic discovery to transcriptomic engineering.
Nature cell biology
· 2020
· Vol. 22
(2)
· pp. 143-150
Abstract
Deployment of RNA-guided DNA endonuclease CRISPR-Cas technology has led to radical advances in biology. As the functional diversity of CRISPR-Cas and parallel systems is further explored, RNA manipulation is emerging as a powerful mode of CRISPR-based engineering. In this Perspective, we chart progress in the RNA-targeting CRISPR-Cas (RCas) field and illustrate how continuing evolution in scientific discovery translates into applications for RNA biology and insights into mysteries, obstacles, and alternative technologies that lie ahead.
Publication Types
["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't", "Review"]
Keywords
MeSH Terms
["Animals", "Animals, Genetically Modified", "CRISPR-Associated Protein 9", "CRISPR-Cas Systems", "Gene Editing", "Genetic Engineering", "Genetic Therapy", "Humans", "Metagenome", "RNA, Guide, CRISPR-Cas Systems", "Transcriptome"]
Funding
U24 HG009889
NHGRI NIH HHS
(United States)
R01 HG004659
NHGRI NIH HHS
(United States)
R01 NS103172
NINDS NIH HHS
(United States)
T32 EB009380
NIBIB NIH HHS
(United States)
U41 HG009889
NHGRI NIH HHS
(United States)
U19 MH107367
NIMH NIH HHS
(United States)
R01 EY029166
NEI NIH HHS
(United States)
R01 GM132106
NIGMS NIH HHS
(United States)